You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET Positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)

Recruiting
  • SSTR2
  • +2 more
  • 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
May 24, 2023

Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

Recruiting
  • Malignancy
  • Al18F-PSMA-BCH PET/CT
  • Beijing, Chaoyang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

Not yet recruiting
  • HER2-positive Breast Cancer
  • 68Ga/131I-SGMIB-5F7
  • Shanghai, China
    Huashan Hospital
Aug 1, 2023

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

    Not yet recruiting
    • Cancer
    • [177Lu]Lu-PSMA I&T
    • Meldola, Forlì, Italy
    • +1 more
    May 10, 2023

    HER2-Positive Cancer Trial in Wuhan

    Active, not recruiting
    • HER2-Positive Cancer
      • Wuhan, Hubei, China
        TongjiHospital
      Sep 7, 2022

      Pancreatic Cancer Trial in Grand Rapids (NMK89)

      Recruiting
      • Pancreatic Cancer
      • Grand Rapids, Michigan
        BAMF Health
      Nov 8, 2023

      Breast Cancer Trial in Beijing (18F-FES PET/CT scan)

      Recruiting
      • Breast Cancer
      • 18F-FES PET/CT scan
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Nov 4, 2022

      Breast Cancer Female, Node-positive Breast Cancer, Sentinel Lymph Node Trial in Milano (PET/MRI)

      Recruiting
      • Breast Cancer Female
      • +2 more
      • PET/MRI
      • Milano, MI, Italy
        Ospedale San Raffaele
      Aug 3, 2022

      68-Ga DOTATATE PET/MRI in Diagnosis and Management of

      Recruiting
      • CNS Tumors
      • +6 more
      • Ga68-DOTATATE-PET/MRI
      • New York, New York
        Weill Cornell Medicine
      Sep 20, 2022

      Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

      Not yet recruiting
      • Marginal Zone Lymphoma
      • (no location specified)
      Nov 6, 2023

      HER2-positive Breast Cancer Trial in Birmingham ([18F]FMISO PET/MRI imaging)

      Recruiting
      • HER2-positive Breast Cancer
      • [18F]FMISO PET/MRI imaging
      • Birmingham, Alabama
        The University of Alabama at Birmingham
      Dec 8, 2022

      Myeloma Trial in Denmark, Norway, Sweden (Carfilzomib, Lenalidomide, PET-CT)

      Recruiting
      • Myeloma
      • Copenhagen, Denmark
      • +3 more
      Sep 15, 2021

      Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

      Not yet recruiting
      • Anatomic Stage II Breast Cancer AJCC v8
      • +3 more
      • (no location specified)
      Jan 24, 2023

      Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

      Not yet recruiting
      • Prostatic Neoplasm
      • (no location specified)
      Apr 27, 2023

      Esophageal Tumors, Gastric Tumors Malignant, Breast Cancer Trial in Stockholm ([68Ga]Ga-ABY-025 PET, Biopsy and analysis of HER2

      Recruiting
      • Esophageal Neoplasms
      • +3 more
      • [68Ga]Ga-ABY-025 PET
      • Biopsy and analysis of HER2 expression
      • Stockholm, Sweden
        Department of Radiation Physics and Nuclear Medicine, Karolinska
      Nov 25, 2022

      Uterine Cervical Tumors, Uterine Tumors Trial in Copenhagen, Herlev, Odense (SLN mapping and removal of PET-positive lymph

      Recruiting
      • Uterine Cervical Neoplasms
      • Uterine Neoplasms
      • SLN mapping and removal of PET-positive lymph nodes
      • Copenhagen, Denmark
      • +2 more
      May 23, 2022

      Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)

      Recruiting
      • Breast Cancer
      • axillary surgery de-escalation after NAT
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center Shanghai, China, 200032
      Jun 13, 2023

      FDG PET/CT in Breast Cancer Bone Mets

      Active, not recruiting
      • Estrogen Receptor Positive Breast Cancer
      • Bone Metastases
      • FDG PET/CT scan
      • Philadelphia, Pennsylvania
        University of Pennsylvania Hospital
      Oct 13, 2022

      Breast Cancer, Prostate Cancer, Brain Tumor Trial in Beijing (68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26)

      Recruiting
      • Breast Cancer
      • +3 more
      • Beijing, China
        Peking Union Medical College Hospital
      Sep 18, 2022

      PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

      Recruiting
      • Pancreatic Cancer
      • +4 more
      • PET Scan
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 10, 2023